Xinyu Bao
Weifang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The Ki-67 proliferation index in tertiary lymphoid structures as a predictor of survival outcomes in patients with resectable non-small cell lung cancer.
Journal: BMC cancer
Published: March 28, 2026
Development of a novel immune infiltration-based gene signature to predict prognosis and immunotherapy response of a novel anti-PD-L1/TGF-β bifunctional fusion protein in recurrent cervical cancer.
Journal: Human vaccines & immunotherapeutics
Published: March 23, 2026
ΔAverage of long and short axis diameter on non-contrast CT is associated with major pathological response to neoadjuvant immunotherapy in resectable non-small cell lung cancer.
Journal: European radiology
Published: November 27, 2025
Association of systemic inflammatory markers and tertiary lymphoid structures with pathological complete response in patients with advanced lung adenocarcinoma receiving preoperative treatment: a retrospective cohort study.
Journal: Journal of thoracic disease
Published: July 29, 2025
Continuing immune checkpoint inhibitors after pseudoprogression improves survival in lung cancer patients: a systematic review and meta-analysis.
Journal: Journal of thoracic disease
Published: July 08, 2025
High endothelial venules abundance in tertiary lymphoid structures: a prognostic biomarker in non-small cell lung cancer with neoadjuvant immunochemotherapy.
Journal: BMC cancer
Published: April 15, 2025
Advances in Multimodal Imaging Techniques for Evaluating and Predicting the Efficacy of Immunotherapy for NSCLC.
Journal: Cancer management and research
Published: February 11, 2025
Predictive biomarkers for immune checkpoint inhibitors therapy in lung cancer.
Journal: Human vaccines & immunotherapeutics
Published: October 17, 2024
Tertiary Lymphoid Structure in Tumor Microenvironment and Immunotherapy of Lung Cancer.
Journal: Archivos de bronconeumologia
Published: May 08, 2024
Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy.
Journal: Frontiers in immunology
Published: April 06, 2024
Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis.
Journal: International immunopharmacology
Published: March 05, 2024
The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD.
Journal: BMC cancer
Published: November 09, 2023
Last Updated: 09/26/2026